Inspire Investing, LLC Lantheus Holdings, Inc. Transaction History

Inspire Investing, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$55.6 - $77.89 $512,576 - $718,067	9,219 Added 233.69%	13,164 $816,000
Q3 2023 Oct 26, 2023	SELL	$60.27 - $90.75 $164,537 - $247,747	-2,730 Reduced 40.9%	3,945 $274,000
Q2 2023 Jul 31, 2023	BUY	$82.41 - $99.65 $14,668 - $17,737	178 Added 2.74%	6,675 $560,000
Q1 2023 Apr 24, 2023	BUY	$47.76 - $82.86 $310,296 - $538,341	6,497 New	6,497 $536,000
Q3 2021 Nov 09, 2021	SELL	$24.23 - $28.59 $300,645 - $354,744	-12,408 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$19.51 - $27.64 $7,335 - $10,392	376 Added 3.13%	12,408 $343,000
Q1 2021 Apr 30, 2021	SELL	$13.77 - $21.66 $59,706 - $93,917	-4,336 Reduced 26.49%	12,032 $257,000
Q4 2020 Feb 12, 2021	BUY	$10.75 - $14.91 $31,992 - $44,372	2,976 Added 22.22%	16,368 $221,000
Q3 2020 Nov 16, 2020	BUY	$11.98 - $16.34 $160,436 - $218,825	13,392 New	13,392 $170,000

531

68.6M

679K

414K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.36B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.